Neuronetics, Inc.

STIM ·Healthcare, Medical Devices, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $28.1M $18.5M $59.7M $70.3M $94.1M $49.0M $75.7M $104.6M
Accounts Receivable $16.5M $23.4M $15.8M $13.6M $7.7M $7.2M $6.6M $5.6M
Inventory $4.3M $4.2M $8.1M $8.9M $6.6M $3.7M $2.8M $2.4M
Total Current Assets $61.6M $58.1M $93.8M $98.8M $115.3M $65.0M $88.5M $114.5M
Property, Plant & Equipment $4.5M $6.2M $2.0M $2.0M $1.2M $730.0K $1.1M $1.4M
Goodwill $23.6M $18.6M
Intangible Assets (Excl. Goodwill) $18.1M $19.6M
Total Assets $141.6M $140.9M $115.8M $116.9M $141.2M $78.7M $100.2M $117.0M
Liabilities
Accounts Payable $10.7M $11.1M $4.8M $2.4M $4.3M $3.7M $4.6M $3.8M
Total Current Liabilities $30.5M $31.3M $19.8M $33.2M $15.7M $13.7M $27.7M $13.6M
Long-Term Debt $65.8M $55.2M $59.3M $22.8M $35.3M $34.6M $19.9M $30.4M
Total Liabilities $115.3M $109.1M $81.6M $59.8M $56.0M $53.2M $52.3M $46.0M
Stockholders' Equity
Retained Earnings $-458.8M $-419.8M $-376.1M $-345.9M $-308.7M $-277.5M $-250.1M $-221.0M
Total Stockholders' Equity $22.4M $27.7M $34.2M $57.1M $85.2M $25.5M $47.9M $71.0M
← Newer Page 1 of 2 Older →